
Beedan 70mg Tablet
Marketer
Adley Formulations
Salt Composition
Dasatinib (70mg)
Overview Beedan 70mg Tablet
Chronic myeloid leukemia (CML) is treated with Beedan 70mg tablets, specifically for patients whose condition is unresponsive to, or intolerable due to side effects from, alternative leukemia therapies. Administer Beedan 70mg daily, at the same time each day, with or without food, for optimal results. Dosage and frequency are determined by your physician, tailored to your condition and subject to adjustment. Strict adherence to the prescribed regimen is crucial; improper use or overdose risks severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue use only under your doctor's guidance. Common side effects include nausea, vomiting, abdominal pain, and rash; less frequently, it may cause irregular heartbeat or fluctuating blood pressure, necessitating immediate medical attention. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of taking Beedan. Reduced blood cell counts, increasing infection risk, necessitate regular blood tests. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if experiencing dizziness or blurred vision.
Uses of Beedan 70mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Beedan 70mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Beedan 70mg Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Beedan 70mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Beedan 70mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Beedan 70mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Beedan 70mg Tablet works:
Beedan 70mg tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a malfunctioning protein responsible for triggering uncontrolled cancer cell proliferation, thus impeding or reducing cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Beedan 70mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Beedan 70mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's inadvisable. Nevertheless, a physician might exceptionally prescribe it in emergencies where potential benefits outweigh the known hazards. Seek medical advice before use.
Breast feedingUNSAFE
Lactation and Beedan 70mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Beedan 70mg Tablet side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Beedan 70mg Tablet.
KidneySAFE IF PRESCRIBED
Beedan 70mg tablets are likely safe for individuals with kidney disease. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver impairment may safely use Beedan 70mg tablets without requiring any dosage modifications.
What if you forget to take Beedan 70mg Tablet :
Omit any missed Beedan 70mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Beedan 70mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Compounds derived from pyrimidine and thiazole. |
| Addictive | None. |
| Medication Classification | Cancer therapies |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |
